Evidence, Insight and Strategy for Optimizing Health Benefits

Tuesday, July 9 - Thursday, July 11, 2019
Harvard Medical School, Boston, MA

Registration coming soon!

harvard medical school: executive education
Conference begins in:

François de Brantes, MBA

Senior Vice President of Commercial Business Development
Remedy Partners

Niteesh K. Choudhry, MD, PhD

Professor of Medicine
Harvard Medical School
Professor in the Department of Health Policy and Management
Harvard T.H. Chan School of Public Health
Executive Director for the Center for Healthcare Delivery Sciences
Brigham and Women’s Hospital

Professor of Medicine at Harvard Medical School, Professor in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health and Executive Director for the Center for Healthcare Delivery Sciences at Brigham and Women’s Hospital, where he also a practicing hospitalist. He is also Director of Implementation Research and Education for Harvard Catalyst.
Much of Dr. Choudhry’s research deals with design and evaluation of novel strategies to increase the use of evidence-based therapies for common conditions such as heart disease and diabetes. He is particularly interested in changing patient and provider behavior and his work draws inspiration from a broad range of fields including clinical medicine, economics, cognitive psychology, epidemiology and biostatistics. His largest ongoing projects seek to combine approaches from behavioral science and machine learning in order to develop scalable solutions for health quality improvement. He and his research team are funded by a variety of public and private sources including the National Institutes of Health, health insurers, pharmaceutical manufactures and private foundations.
Dr. Choudhry attended McGill University, received his M.D. and completed his residency training in Internal Medicine at the University of Toronto and then served as Chief Medical Resident for the Toronto General and Toronto Western Hospitals. He earned his Ph.D. in Health Policy from Harvard University with a concentration in Statistics and the Evaluative Sciences. His research has been widely published in leading medical and policy journals and has won numerous awards for excellence in research, teaching and mentorship.

Suzanne F. Delbanco

Executive Director
Catalyst for Payment Reform
Berkeley, California

Ms. Delbanco is the executive director of Catalyst for Payment Reform (CPR). CPR is an independent, nonprofit corporation working to catalyze employers, public purchasers and others to implement strategies that produce higher value health care and improve the functioning of the health care marketplace. In addition to her duties at CPR, she serves on the advisory board of the Blue Cross Blue Shield Institute and participates in the health care executives’ leadership network. Previously, Ms. Delbanco was the founding chief executive officer of The Leapfrog Group. She holds a Ph.D. degree in public policy from the Goldman School of Public Policy and an M.P.H. degree from the school of public health at the University of California, Berkeley.

Rushika Fernandopulle, M.D., M.P.P

Co-Founder and CEO
Iora Health
Boston, Massachusetts

Dr. Fernandopulle is co-founder and CEO of Iora Health, a leader in the design and implementation of high-performing, innovative health care delivery systems. For the past seven years, he has worked with a select group of progressive physician groups, hospitals, union trusts, employers and public agencies to create new ways to deliver care to dramatically improve quality and service and reduce overall expenditures. Prior to this, Dr.Fernandopulle was the first executive director of the Harvard Interfaculty Program for Health Systems Improvement and managing director of the Clinical Initiatives Center at the Advisory Board Company. He is the co-author or editor of several publications including Health Care Policy, a textbook for physicians and medical students, and Uninsured in America: Life and Death in the Land of Opportunity. Dr. Fernandopulle serves on the staff at Massachusetts General Hospital and on the faculty of Harvard Medical School. He earned his A.B., M.D. and M.P.P. degrees from Harvard University, and completed his clinical training at the University of Pennsylvania and Massachusetts General Hospital.

Nancy L. Keating, M.D., M.P.H.

Professor, Health Care Policy and Medicine
Harvard Medical School
Physician
Brigham and Women's Hospital

Nancy L. Keating is a professor of health care policy and medicine at Harvard Medical School and a physician at Brigham and Women's Hospital. Dr. Keating's research examines provider, patient, and health system factors that influence the delivery of high-quality care for individuals with cancer. 

Dr. Keating is currently evaluating the Center for Medicare and Medicaid Service's Oncology Care Model, a new payment and delivery model for oncology practices administering chemotherapy. This model aims to use appropriately aligned financial incentives to improve care coordination, appropriateness of care, and access to care for Medicare beneficiaries undergoing chemotherapy at approximately 250 practices in the U.S., and the evaluation will assess patients' experiences with care, quality of care, health care utilization, and outcomes. 

Dr. Keating is a longstanding member of the Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium, funded by the National Cancer Institute (NCI). This is a collaborative effort among investigators at seven sites to examine patterns of care and outcomes for patients with colorectal and lung cancer. Using CanCORS data linked with Medicare administrative data, she is seeking to better understand patient, physician, and health system factors contributing to the variations in the intensity of end-of-life (EOL) care for individuals with advanced cancer. In other work funded by the NCI, she is examining the influence of physician networks on care to understand the diffusion of cancer care practices over time, focusing on the use of new biologic therapies for cancer and care at the end of life. 

In another project funded by the NCI, Dr. Keating is using data from the Massachusetts Cancer Registry linked with the Massachusetts All-Payer Claims Database to examine variations in the quality and costs of cancer care across provider networks in Massachusetts. Dr. Keating also has a K24 grant from the NCI that is applying from behavioral economics techniques to improve discussions and understanding of goals of chemotherapy for individuals with advanced cancer. Finally, with funding from the American Cancer Society, she is examining the impact of oral cancer drug parity laws, which have been adopted in 23 states since 2007, to ensure that patients pay no more for oral anti-cancer therapies than they pay for intravenous therapies offered by the same health plan. Findings from this study will inform current efforts in Congress to pass similar national legislation. 

Dr. Keating received her MD from the University of Chicago Pritzker School of Medicine and her MPH from the Harvard School of Public Health. She was awarded the Outstanding Junior Investigator Award from the Society of General Internal Medicine in 2005. She is an associate editor at the Journal of the National Cancer Institute, a member of the editorial board of the Journal of Geriatric Oncology, and a member of the National Comprehensive Cancer Center Senior Oncology Guideline Panel. She recently completed 3-year terms on the Council of the Society of General Internal Medicine and the American Society of Clinical Oncology Clinical Practice Guidelines Committee. Dr. Keating recently served on the Institute of Medicine Committee: Clinical Guidance for the Care of Health Conditions Identified by the Camp Lejeune Legislation.

Aaron Kesselheim M.D., J.D., M.P.H.

Associate Professor of Medicine
Harvard Medical School
Faculty Member, Division of Pharmacoepidemiology and Pharmacoenomics
Department of Medicine
Brigham and Women's Hospital

Aaron S. Kesselheim, M.D., J.D., M.P.H., is an Associate Professor of Medicine at Harvard Medical School and a faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women's Hospital. He graduated from Harvard College and received his postgraduate training at the University of Pennsylvania School of Medicine and Law School, and most recently at the Harvard School of Public Health. He is Board Certified in Internal Medicine, and serves as a primary care physician at the Phyllis Jen Center for Primary Care at BWH. His research focuses on the effects of intellectual property laws and regulatory policies on pharmaceutical development, the drug approval process, and the costs, availability, and use of prescription drugs both domestically and in resource-poor settings. He has also investigated how other issues at the intersection of law and public health can affect the health care system, including health care fraud, expert testimony in malpractice cases, and insurance reimbursement practices. He is a member of the New York State Bar and is a Patent Attorney.

Within the Division, Dr. Kesselheim leads the Program On Regulation, Therapeutics, And Law (PORTAL), an interdisciplinary research core focusing on intersections among prescription drugs and medical devices, patient health outcomes, and regulatory practices and the law. In 2013, Dr. Kesselheim was named a Greenwall Faculty Scholar in Bioethics by the Greenwall Foundation, which supports innovative empirical research in bioethics. Dr. Kesselheim's work is also currently funded by the FDA, Laura and John Arnold Foundation, and by a Robert Wood Johnson Investigator Award in Health Policy Research. In the past, he has received research support from the Edmond J. Safra Center for Ethics at Harvard University, AHRQ, Pew Charitable Trusts, and the Harvard Clinical and Translational Science Center.

Joe Kimura, MD, MPH

Chief Medical Officer
Atrius Health


Jeff Levin-Scherz, M.D., M.B.A., F.A.C.P.

Assistant Professor
Harvard Medical School
Harvard T.H. Chan School of Public Health

Jeff Levin-Scherz is an assistant professor at Harvard Medical School and the Harvard T.H. Chan School of Public Health and a senior consultant and the co-leader of North American Health Management Practice at Willis Towers Watson. He helps large employers develop, implement and evaluate their health management strategy, including care management programs, incentive programs, and technology programs. Jeff leads intellectual capital development for Willis Towers Watson in the Health Management space.

Jeff has written and spoken widely on health care delivery and reform, especially around the adoption of disruptive innovation, and the use of behavioral economics to drive performance in the health care delivery system and behavior among employees and in the general population.  His work has been published in JAMA, the Journal of General Internal Medicine, and the Harvard Business Review. He is a co-author of "Human Centric Health: Behavior Change and Prevention of Non-Communicable Diseases" presented at the World Economic Forum in Davos, Switzerland, in January, 2017

Jeff has a broad range of experience in health care delivery and finance. He was the President of a regional independent practice association, Chief Medical Officer of the network division of Partners HealthCare and of Atrius Health, a multispecialty group with 1000 physicians, as well as One Medical, a venture funded national high tech high touch primary care practice. Jeff also served for seven years as a vice president of Tufts Health Plan, a top-ranked regional health plan. Jeff holds an M.D. from the Boston University School of Medicine, and received his M.B.A. from Columbia Business School.

Ateev Mehrotra, M.D., M.P.H.

Associate Professor of Health Care Policy and Medicine
Harvard Medical School
Hospitalist
Beth Israel Deaconess Medical Center

Ateev Mehrotra, is an associate professor of health care policy and medicine at Harvard Medical School and a hospitalist at Beth Israel Deaconess Medical Center. Dr. Mehrotra's research focuses on interventions to decrease costs and improve quality of care. Much of his work has focused on innovations in delivery such as retail clinics and telemedicine and their impact on quality, costs, and access to health care. He is also interested in the role of consumerism and whether price transparency and public reporting of quality can impact patient decision making. Related work has focused on quality measurement, including how natural language processing can be used to analyze the data in electronic health records to measure the quality of care. Dr. Mehrotra received his BS from the Massachusetts Institute of Technology, his medical degree from the University of California, San Francisco and his residency in internal medicine and pediatrics at the Massachusetts General Hospital and Children's Hospital of Boston. His clinical work has been both as a primary care physician and as an adult and pediatric hospitalist. He also has received formal research training with a Master of Public Health from the University of California, Berkeley and a Master of Science in Epidemiology from the Harvard School of Public Health. In 2013, he received the Alice S. Hersh New Investigator Award from AcademyHealth for health services researchers early in their careers who show exceptional promise

Jeremy Nobel, MD, MPH

Faculty
Center for Primary Care, Harvard Medical School
Department of Global Health and Social Medicine
Principal, Nobel & Associates

Dr. Nobel is a medical doctor, public health practitioner and innovator who designs, implements and evaluates health care management, digital therapeutic and patient/consumer engagement systems. Working with employers and other purchasers, as well as health plans and providers, his efforts enable value-based care delivery while optimizing essential aspects of care delivery and improving outcomes.

Nobel’s work focuses particularly on emerging digital opportunities like remote physiologic monitoring, hand-held devices, “smart” registries, machine learning and AI, large scale data analytics, and related software applications. Nobel’s contributions have been the basis of significant acute care and chronic care advances including improvements in behavioral health, diabetes care and cardiovascular care, as well as hospital quality and safety. His work is focused on streamlining and systematizing care delivery wherever it can be best managed and includes homes and workplaces as care delivery environments.

In addition to his academic teaching and research, Nobel works in consultation to employers, major health plans, Taft-Hartley trusts, medical device and pharmaceutical companies, early stage ventures, non- profit organizations and foundations in the design and evaluation of effective health care management programs. These include Blue Cross/Blue Shield of Massachusetts, Aetna, Humana, SCAN Health Plan J&J, Chrysler, GM, Safeway, Prudential, Goldman Sachs, Sanofi-Aventis, Pfizer, GSK, Verizon, CAREMARK, IBM, WebMD, Medtronic, McKesson, Leapfrog Group, Association for Managed Care Pharmacy, the National Academy of Medicine, Blue Shield of CA Foundation, the California Health Care Foundation (CHCF) and the California Endowment. In addition, he served as Medical Director at the Northeast Business Group on Health (NEBGH) for eight years (2010-18) where he founded and ran the NEBGH Solutions Center.

Dr. Nobel is a Lecturer in the Department of Global Health and Social Medicine at Harvard Medical School (HMS) and serves on the Faculty for the HMS Center for Primary Care. He is Board Certified in both Internal Medicine and Preventive Medicine, with dual Master’s Degrees in Public Health and Epidemiology from the Harvard T.H. Chan School of Public Health. He graduated magna cum laude from Princeton University.

Meredith Rosenthal, Ph.D.

Senior Associate Dean for Academic Affairs, Professor of Health Economics and Policy
Harvard Medical School
Harvard T.H. Chan School of Public Health

Dr. Rosenthal is Senior Associate Dean for Academic Affairs,
Professor of Health Economics and Policy, Harvard TH Chan School of Public Health. She received her B.A in International Relations (Commerce) from Brown University in 1990 and her Ph.D. in Health Policy (Economics track) from Harvard University in 1998.

Her research focuses primarily on policies that will help slow the growth in healthcare spending and improve value. These efforts include changes in payment incentives, benefit design, and the provision of information and behavioral "nudges" to both patients and providers. Her research has influenced the design of provider payment systems in both the public and private sectors. She has advised federal and state policymakers in healthcare payment policy and implementation. She has also testified in Congressional hearings on direct-to-consumer advertising of prescription drugs and pay-for-performance and in legislative hearings in California and Massachusetts concerning healthcare provider payment and benefit design policies.

Dr. Rosenthal is a member of the Committee on Higher Degrees in Health Policy, the Massachusetts Center for Healthcare Information and Analysis Oversight Board, and Board Chair of Massachusetts Health Quality Partners, a multi-stakeholder quality improvement organization. Dr. Rosenthal's work has been published in the New England Journal of Medicine, the Journal of the American Medical Association, Health Affairs, and numerous other peer-reviewed journals. In 2014, Dr. Rosenthal was elected to the Institute of Medicine (recently renamed the National Academy of Medicine).

Stanley Y. Shaw, M.D., Ph.D.

Associate Dean for Executive Education
Harvard Medical School
Board - Certified Cardiologist

Stanley Y. Shaw, M.D., Ph.D.  is the Associate Dean for Executive Education at Harvard Medical School. In this role, he designs and leads customized, experiential executive programs for companies and individuals from diverse sectors of health care, including technology, health IT, internet search, biopharmaceuticals, and investing. He is the Chief Scientific Officer for One Brave Idea (at Brigham and Women's Hospital), a $75M initiative funded by the American Heart Association, Verify (formerly Google Life Sciences) and Astra Zeneca to understand and treat the underlying causes of coronary heart disease. He leads reserach efforts in digial health, bioinformatics, the gut microbiome and non-traditional streams of patient-reported data. Previously, Dr. Shaw co-founded the Center for Assessment Technology and Continious Health (CATCH) at Massachusetts General Hospital (MGH), and his team led the development of one of the first ResearchKit iPhone apps (for type 2 diabetes) in partnership with Apple. He is a board-certified cardiologist. 

Zirui Song, M.D., Ph.D.

Assistant Professor
Harvard Medical School
Internal Medicine Physician
Massachusetts General Hospital

Zirui Song, M.D., Ph.D. is an assistant professor of health care policy at Harvard Medical School and a primary care physician at Massachusetts General Hospital. Dr. Song's research focuses on the impact of payment reform on health care spending and quality, the impact of Medicare fee policies on spending and physician behavior, and the economics of private plans in Medicare. This work has been published in the New England Journal of Medicine, JAMA, Health Affairs, and Journal of Health Economics.

Dr. Song is a recipient of the AcademyHealth Article-of-the-Year award, Award for Clinician Investigation from the New England Society of General Internal Medicine, and the Emerging Leader in Managed Care Research Award from the American Journal of Managed Care. He has received three Certificates of Distinction in teaching from Harvard College and two teaching awards at Harvard Medical School. He has worked on policy issues in the Department of Health and Human Services in Washington, D.C., served as a visiting fellow in the Health Policy Commission for the state of Massachusetts, and was a special guest in the Center for Social and Economic Dynamics at the Brookings Institution.

Dr. Song completed his residency training at Massachusetts General Hospital, where he was selected by peers for the Morton N. Swartz, M.D. Humanism in Medicine Award. He received his M.D. from Harvard Medical School, magna cum laude, and Ph.D. in Health Policy (Economics track) from Harvard University, where he was a fellow in Aging and Health Economics at the National Bureau of Economic Research.

Daniel Stein, M.D.

CEO and Founder
Better Medicine
Clinical and Strategy Advisor
Walmart 


Daniel Stein is the CEO and Founder of Better Medicine, a provider analytics and network optimization company. He also serves as a clinical and strategy advisor for Walmart. Daniel previously worked as Chief Medical Officer for Walmart Care Clinics, where he co-founded and led Walmart's primary care clinic business, Walmart Care Clinics, as well as other healthcare initiatives. Previously, Daniel worked on the health staff of the U.S. Senate Finance Committee on policy involving Medicare and Medicaid. In this capacity, Daniel worked extensively on the Medicare Modernization Act of 2003, the Medicare prescription drug legislation, and medical malpractice reform. Daniel returned the U.S. Senate Finance Committee in 2009 to help formulate health care workforce and delivery system reform proposals for Senator Baucus' comprehensive health reform buill which formed the foundation for the Accountable Care Act. Daniel also worked previously at the Centers for Medicare and Medicaid Services (CMS) where his work focused on Medicare quality and pay-for-performance initiatives.

In addition, Daniel also practices part-time as primary care physician at the Veterans Health Care Systems of the Ozarks in Fayetteville, Arkansas. 

Daniel received his undergraduate degree in Ethics, Politics, and Economics from Yale College; his medical degree from the Johns Hopkins School of Medicine; and his MBA from the Harvard Business School. He completed his residency in primary care internal medicine at Brigham and Women's Hospital where he was honored with the John H. McArthur Fellowship in Medicine and Management.

Charlotte S. Yeh, M.D.

Chief Medical Officer
AARP Services, Inc.

Dr. Charlotte Yeh is the Chief Medical Officer for AARP Services, Inc. In her role, Dr. Yeh works with the independent carriers that make health-related products and services available to AARP members, to identify programs and initiatives that will lead to enhanced care for older adults
Dr. Yeh has more than 30 years of healthcare experience – as a practitioner and Chief of Emergency Medicine at Newton-Wellesley Hospital and Tufts Medical Center, as the Medical Director for the National Heritage Insurance Company, a Medicare Part B claims contractor, and as the Regional Administrator for the Centers for Medicare and Medicaid Services in Boston.
Dr. Yeh is widely recognized for her commitment to and passion for the healthcare consumer and has received numerous honors and awards for her efforts on behalf of patients. As a health care leader, she has served on numerous boards and committees throughout her career, and currently sits on the Optum Labs Scientific Advisory Board. She is also a member of the Advisory Council for the National Institute on Deafness and Other Communicable Disorders, the Personal Connected Health Alliance Board of Managers and Board of Directors for The Schwartz Center for Compassionate Care.
Dr. Yeh received a BA from Northwestern University and her medical degree from Northwestern University Medical School. She completed her internship in General Surgery at the University of Washington and her residency in Emergency Medicine at UCLA.